Our news

  • In this blog for people living with a brain tumour, healthcare practitioners and anyone with an interest in brain tumours, Helen Bulbeck, Cochrane consumer representative and director of policy and services for brainstrust, looks at the latest Cochrane evidence on brain tumours and reflects on what this special collection means for the...
    March 18 2021
  • Help Cochrane improve the way we share evidenceThe past year has shown how important high quality evidence is. Here at Cochrane, we create short simple summaries of our reviews called Plain Language Summaries. These summaries are meant to be accessible by people around the world, so they can use them to make health care decisions. We would like...
    January 26 2021
  • James Lind Alliance (JLA) Priority Setting Partnerships enable clinicians, patients and caregivers to work together to identify and prioritise the most important areas of clinical research that could be answered by well-designed studies. In June 2015, the top 10 priorities for clinical research in primary brain and spinal cord tumours ...
    September 17 2020
  • Cochrane UK continues to offer virtual Review Author Training workshops to authors of Cochrane Intervention Reviews.There are four core workshops to help authors at different stages of review preparation, from beginning a review protocol through to completing the review. ·         RA1 Beginning a...
    August 3 2020
  • Measurement of β‐D‐glucans to detect invasive fungal infection in immunocompromised peopleWhy is improving the diagnosis of invasive fungal infections important?Fungal infections occur in people who are unable to fight infection, and these infections can be life‐threatening in this group of people. Fungal infections are difficult to diagnose....
    July 23 2020
  • Cochrane Community BlogEve Tomlinson, NIHR Network Support Fellow for the Cochrane Cancer Network presents the work completed across the cancer network to complete an exercise in stakeholder mapping.The Cochrane Cancer Network supports the work of six Cochrane Review Groups (CRGs): Breast Cancer, Childhood Cancer, Gynaecological, Neuro-oncology...
    June 24 2020
  • Telephone interventions for managing symptoms in adults with cancer. This is particularly important at the moment for people with cancer, who have been advised to stay at home due to COVID-19.People with cancer experience a variety of symptoms such as depression, anxiety, fatigue and pain caused by their disease and its treatment. These are often...
    June 3 2020
  • COVID-19 (coronavirus disease) - Cochrane Gynaecological, Neuro-oncology and Orphan CancersCoronavirus disease (COVID-19) is caused by a new strain of Coronavirus (SARS-CoV-2) discovered in 2019, and not previously identified in humans. Common symptoms include fever, cough, and shortness of breath. On March 11 2020, the World Health Organization (...
    April 14 2020
  • The aim of the register is to support rapid evidence synthesis by all systematic review producers, including Cochrane's work on Rapid Reviews in response to COVID-19. The register helps systematic reviewers prioritize topics, identify available evidence, and produce urgently needed reviews for front-line health professionals, public health...
    April 8 2020
  • COVID-19 pandemic: statement for CGNOC collaborators and colleaguesWe recognise that these are uncertain times and the impact of the COVID-19 pandemic will be felt by many of our collaborators and colleagues. We want to reassure all of you that your health, and your current priorities at work and home, are of the utmost importance to us.For those...
    March 30 2020

Pages

Subscribe to Our news